MOORE CAPITAL MANAGEMENT, LP – United Therapeutics Corporation Transaction History
MOORE CAPITAL MANAGEMENT, LP portfolio value:
$18.84M
portfolio value
MOORE CAPITAL MANAGEMENT, LP quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +21.45% | 15.89K shares | 1.38M | $209.38 | 89.97K |
| Q2 2022 | share | Increase | +0.54% | 401 shares | 4.23M | $235.64 | 74.08K |
| Q1 2022 | share | Increase | +7.06% | 4.85K shares | -1.65M | $179.41 | 73.68K |
| Q4 2021 | share | Decrease | -41.83% | -49.48K shares | -6.96M | $215.18 | 68.82K |
| Q3 2021 | share | Increase | +33.40% | 29.62K shares | 5.92M | $184.58 | 118.31K |
| Q2 2021 | share | Increase | 0.00% | 88.69K shares | 15.91M | $179.41 | 88.69K |